Atara Biotherapeutics, Inc. (ATRA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.5
Day's range
$7.3

Atara Biotherapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ECOR1 CAPITAL, LLC 08/14/2026 1.55 M $17.82 M   1,458.34% 11.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 850.00 K $9.76 M   21.43% 6.04%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 687.72 K $7.90 M   254.01% 4.88%
REDMILE GROUP, LLC 08/14/2026 441.70 K $5.07 M   0.00% 3.14%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 247.05 K $2.84 M   13.40% 1.75%
MACKENZIE FINANCIAL CORP 08/13/2026 233.25 K $2.68 M   -25.63% 1.66%
BLACKROCK, INC. 08/07/2026 84.46 K $969.54 K   6.88% 0.60%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 75.13 K $862.92 K   13.58% 0.53%
STALEY CAPITAL ADVISERS INC 08/11/2026 50.00 K $574.00 K   0.00% 0.36%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 43.04 K $494.05 K   28.00% 0.31%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 38.85 K $444.00 K   -70.33% 0.28%
JANE STREET GROUP, LLC 08/14/2026 30.35 K $348.36 K   -10.41% 0.22%
STATE STREET CORP 08/07/2026 26.45 K $303.68 K   0.00% 0.19%
NORTHERN TRUST CORP 08/13/2026 16.59 K $190.47 K   34.45% 0.12%
FMR LLC 08/13/2026 16.24 K $186.41 K   0.00% 0.12%
XTX TOPCO LTD 08/14/2026 15.30 K $175.68 K   100.00% 0.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 14.00 K $160.72 K   -57.17% 0.10%
MILLENNIUM MANAGEMENT LLC 08/14/2026 12.68 K $145.57 K   -73.41% 0.09%
CITADEL ADVISORS LLC 08/14/2026 10.16 K $116.63 K   100.00% 0.07%
MORGAN STANLEY 08/13/2026 9.18 K $105.37 K   0.10% 0.07%
ROYAL BANK OF CANADA 08/14/2026 4.74 K $55.00 K   9.82% 0.03%
UBS GROUP AG 08/13/2026 3.98 K $45.68 K   -92.05% 0.03%
VANGUARD GLOBAL ADVISERS, LLC 08/13/2026 1.46 K $16.72 K   0.00% 0.01%
SBI SECURITIES CO., LTD. 07/23/2026 1.40 K $16.12 K   -10.80% 0.01%
JONES FINANCIAL COMPANIES LLLP 08/14/2026 803 $8.44 K   14.22% 0.01%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 08/05/2026 311 $3.57 K   100.00% 0.00%
BARCLAYS PLC 08/14/2026 304 $3.49 K   100.00% 0.00%
WELLS FARGO & COMPANY/MN 08/14/2026 251 $2.88 K   0.00% 0.00%
JPMORGAN CHASE & CO 08/12/2026 216 $2.41 K   0.00% 0.00%
RAIFFEISEN BANK INTERNATIONAL AG 08/03/2026 200 $2.30 K   0.00% 0.00%
BANQUE TRANSATLANTIQUE SA 07/30/2026 176 $3.10 K   0.00% 0.00%
CITIGROUP INC 08/03/2026 97 $1.11 K   9,600.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 46 $528   -20.69% 0.00%
KERR FINANCIAL PLANNING CORP 07/02/2026 24 $276   0.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 10 $114   0.00% 0.00%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 08/13/2026 8 $92   0.00% 0.00%
RHUMBLINE ADVISERS 08/12/2026 0 $0   -100.00% 0.00%
WESTERN WEALTH MANAGEMENT, LLC 08/14/2026 0 $0   -100.00% 0.00%

Atara Biotherapeutics Inc institutional Ownership - FAQ's

During the previous two years, 74 institutional investors and hedge funds held shares of Atara Biotherapeutics Inc. The most heavily invested institutionals were:

EcoR1 Capital, LLC: 1.55 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 850,000

Point72 Asset Management, L.P.: 687,718

Redmile Group, LLC: 441,701

VANGUARD CAPITAL MANAGEMENT LLC: 247,047

MACKENZIE FINANCIAL CORP: 233,249

31.73% of Atara Biotherapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 9.81 M shares in the last 24 months. This purchase volume represents approximately $65.52 M in transactions.